Neo-Synephrine® HCl

Neo-Synephrine® HCl

Drug Labeling and Warnings

Drug Details

k">

NEO-SYNEPHRINE HYDROCHLORIDE- phenylephrine hydrochloride injection, solution 
Hospira, Inc.

----------

Neo-Synephrine® HCl

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Label

1 mL
NDC: 0409-1800-01

Neo-Synephrine®
HCl

Rx only

phenylephrine HCl
injection, USP

10 mg/mL

1% Solution
Hospira, Inc.
Lake Forest, IL 60045 USA

RL-1423 (11/05)

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Label

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Cello Pack Label

1 mL (10 mg)
Single-dose
5 Ampuls
NDC: 0409-1800-01

Neo-Synephrine® HCl
phenylephrine hydrochloride injection, USP
1% Sterile Aqueous Injection

FOR PARENTERAL USE
Rx only

PROTECT FROM LIGHT.

Each mL contains 10 mg NEO-SYNEPHRINE hydrochloride,
brand of phenylephrine hydrochloride, 3.5 mg sodium
chloride, 4 mg sodium citrate, 1 mg citric acid monohydrate,
and not more than 2 mg sodium metabisulfite as preservative.
For usual dosage and route of administration, see package
insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled
Room Temperature.]
WARNING: CONTAINS SULFITES.

Printed in USA
Hospira, Inc., Lake Forest, IL 60045 USA
Hospira

RL-2067 (3/07)

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Cello Pack Label
NEO-SYNEPHRINE HYDROCHLORIDE 
phenylephrine hydrochloride injection, solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 0409-1800
Route of AdministrationSUBCUTANEOUS, INTRAMUSCULAR, INTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE10 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) 3.5 mg  in 1 mL
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) 4 mg  in 1 mL
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) 1 mg  in 1 mL
SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 0409-1800-015 in 1 CELLO PACK03/14/2006
11 mL in 1 AMPULE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
EXPORT ONLY03/14/2006
Labeler - Hospira, Inc. (141588017)
Establishment
NameAddressID/FEIBusiness Operations
Hospira, Inc.093132819ANALYSIS(0409-1800) , LABEL(0409-1800) , MANUFACTURE(0409-1800) , PACK(0409-1800)

Revised: 11/2018
 
Hospira, Inc.


© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.